Literature DB >> 16720368

Antisense delivery and protein knockdown within the intact central nervous system.

Michael Cronin1, Patrick N Anderson, Colin R Green, David L Becker.   

Abstract

The ability to down regulate the expression of a specific protein within the intact central nervous system (CNS) is highly desirable from both a research and therapeutic perspective. Antisense has the potential to do this. However, problems of invasive antisense delivery methods and short half life of remain problematic. We overcome this by using Pluronic gel to provide a sustained delivery antisense oligodeoxynucleotides (ODN's) to the intact central nervous system and achieving rapid penetration throughout the spinal cord in 2-3 hours and significant knockdown of our target protein connexin 43 (Cx43) in 4-8 hours (recovering at 48-72 hours). Interestingly CY3-siRNA probes could not be detected penetrating the intact CNS and no knockdown the Cx43 was found. This approach with conventional ODNs could provide a faster and cheaper alternative to knockout mice in the investigation of the functions of specific proteins within the CNS and may also have therapeutic implications for drug discovery and development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720368     DOI: 10.2741/2025

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  8 in total

Review 1.  Cardiac to cancer: connecting connexins to clinical opportunity.

Authors:  Christina L Grek; J Matthew Rhett; Gautam S Ghatnekar
Journal:  FEBS Lett       Date:  2014-03-04       Impact factor: 4.124

2.  In vitro optimization of antisense oligodeoxynucleotide design: an example using the connexin gene family.

Authors:  Lee Yong Law; Wei V Zhang; N Susan Stott; David L Becker; Colin R Green
Journal:  J Biomol Tech       Date:  2006-09

Review 3.  Embryonic wound healing: a primer for engineering novel therapies for tissue repair.

Authors:  Katherine E Degen; Robert G Gourdie
Journal:  Birth Defects Res C Embryo Today       Date:  2012-09

4.  Regulation of connexin43 gap junction protein triggers vascular recovery and healing in human ocular persistent epithelial defect wounds.

Authors:  Susan Ormonde; Chi-Ying Chou; Lucy Goold; Con Petsoglou; Rasha Al-Taie; Trevor Sherwin; Charles N J McGhee; Colin R Green
Journal:  J Membr Biol       Date:  2012-07-15       Impact factor: 1.843

5.  Precise control of miR-125b levels is required to create a regeneration-permissive environment after spinal cord injury: a cross-species comparison between salamander and rat.

Authors:  Juan Felipe Diaz Quiroz; Eve Tsai; Matthew Coyle; Tina Sehm; Karen Echeverri
Journal:  Dis Model Mech       Date:  2014-04-03       Impact factor: 5.758

6.  Effect of connexin 43 inhibition by the mimetic peptide Gap27 on corneal wound healing, inflammation and neovascularization.

Authors:  Hossein Mostafa Elbadawy; Pierfrancesco Mirabelli; Maria Xeroudaki; Mohit Parekh; Marina Bertolin; Claudia Breda; Carlo Cagini; Diego Ponzin; Neil Lagali; Stefano Ferrari
Journal:  Br J Pharmacol       Date:  2016-08-26       Impact factor: 8.739

7.  Intracellular oligonucleotide delivery using the cell penetrating peptide Xentry.

Authors:  Frazer P Coutinho; Colin R Green; Ilva D Rupenthal
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

8.  Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.

Authors:  Agneta Mewes; Heike Franke; David Singer
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.